Have a personal or library account? Click to login
The development of HPLC-DAD method for determination of active pharmaceutical ingredient in the potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio) acetate substance Cover

The development of HPLC-DAD method for determination of active pharmaceutical ingredient in the potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio) acetate substance

Current Issues in Pharmacy and Medical Sciences
Volume 32 (2019): Issue 1 (March 2019)
By: Roman Shcherbyna,  Volodymyr Parchenko,  Boris Varynskyi and  Andriy Kaplaushenko  
Open Access
|Apr 2019
DOI: https://doi.org/10.2478/cipms-2019-0001 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Journal RSS Feed
Language: English
Page range: 5 - 9
Submitted on: Feb 8, 2018
|
Accepted on: Apr 30, 2018
|
Published on: Apr 6, 2019
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
1,
2,
4-triazole,
HPLC-DAD,
an active pharmaceutical ingredient
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Pharmacology, toxicology,
Pharmacy,
Pharmacy, other

© 2019 Roman Shcherbyna, Volodymyr Parchenko, Boris Varynskyi, Andriy Kaplaushenko, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 32 (2019): Issue 1 (March 2019)Next article